Health Catalyst, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $311.1M | $306.6M | $295.9M | $276.2M | $241.9M |
| Operating income | -$160.9M | -$69.8M | -$126.9M | -$140.0M | -$143.7M |
| Operating expenses | $312.5M | $210.6M | $258.7M | $273.2M | $261.2M |
| Cash from operations | $731,000 | $14.6M | -$33.1M | -$35.3M | -$23.1M |
| Capital expenditure | $968,000 | $1.6M | $1.2M | $2.2M | $10.4M |
| Free cash flow | -$237,000 | $12.9M | -$34.3M | -$37.4M | -$33.6M |
| Share repurchases | $5.0M | $0 | $1.8M | $8.4M | $0 |
| Impairments | $105.4M | $0 | $0 | $0 | $0 |
| Total assets | $502.6M | $858.9M | $701.8M | $752.3M | $832.1M |
| Total liabilities | $256.9M | $493.7M | $334.9M | $327.3M | $310.0M |
| Total debt | $160.8M | $392.4M | $230.0M | — | — |
Shares outstanding 73.9M · Free float 80.5%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.